Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
RESEARCH TOOLSreports
RVL Pharmaceuticals (RVLPQ) Financial Statements
310 Followers
RVL Pharmaceuticals Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 8.26M | $ 8.83M | $ 9.81M | $ 10.02M | $ 8.45M |
| Gross Profit | $ 6.31M | $ 6.53M | $ 7.25M | $ 7.50M | $ 6.22M |
| EBIT | $ -23.99M | $ -16.07M | $ -19.47M | $ -13.25M | $ -10.85M |
| EBITDA | $ -23.89M | $ -15.98M | $ -19.37M | $ -13.16M | $ -10.76M |
| Net Income Common Stockholders | $ -23.89M | $ -11.61M | $ -18.32M | $ -14.45M | $ -12.11M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 19.20M | $ 32.60M | $ 44.50M | $ 59.75M | $ 28.54M |
| Total Assets | $ 85.44M | $ 111.07M | $ 128.51M | $ 155.35M | $ 124.83M |
| Total Debt | $ 58.15M | $ 57.75M | $ 57.49M | $ 56.66M | $ 44.41M |
| Net Debt | $ 38.95M | $ 25.15M | $ 12.99M | $ -3.09M | $ 15.87M |
| Total Liabilities | $ 69.08M | $ 71.11M | $ 77.42M | $ 86.81M | $ 66.32M |
| Stockholders Equity | $ 16.35M | $ 40.03M | $ 51.09M | $ 68.55M | $ 58.51M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -13.04M | $ -7.03M | $ -16.57M | $ -10.12M | $ 2.00M |
| Operating Cash Flow | $ -12.08M | $ -5.80M | $ -16.40M | $ -10.10M | $ 2.00M |
| Investing Cash Flow | $ -959.00K | $ -1.23M | $ -172.00K | $ 231.00K | $ 57.00K |
| Financing Cash Flow | $ -460.00K | $ -4.86M | $ 1.40M | $ 42.20M | $ -981.00K |
RVL Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.